Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.

Glioma is a particularly lethal central nervous system tumor. Identifying the boundary between gliomas and normal tissues is difficult due to their infiltrative and invasive growth characteristics. This can result in the inevitable recurrence of the tumor after surgery. Preventing the residual tumor...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong Tian, Xiaoli Chu, Qi Guan, Juan Liu, Ying Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0312055
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849715794532892672
author Hong Tian
Xiaoli Chu
Qi Guan
Juan Liu
Ying Liu
author_facet Hong Tian
Xiaoli Chu
Qi Guan
Juan Liu
Ying Liu
author_sort Hong Tian
collection DOAJ
description Glioma is a particularly lethal central nervous system tumor. Identifying the boundary between gliomas and normal tissues is difficult due to their infiltrative and invasive growth characteristics. This can result in the inevitable recurrence of the tumor after surgery. Preventing the residual tumor from growing or spreading is a major obstacle in treating gliomas. An earlier study suggested that hypotaurine could enhance the invasion of glioma cells while inhibiting the activity of demethylases. The hypotaurine synthesis-deficient U251 cell line usage showed a decrease in the cells' invasion capability. Analysis of gene expression profiles showed that reducing the activity of a critical enzyme in hypotaurine production, 2-aminoethanethiol dioxygenase (ADO), had a notable effect on the extracellular matrix-receptor interaction. Decreased intracellular ADO expression led to a significant increase in Wnt5a expression. Cells exposed to hypotaurine exhibited decreased levels of both intracellular Wnt5a protein and its corresponding mRNA. The observed characteristic was linked to increased methylation of the Wnt5a gene promoter, possibly due to hypotaurine's ability to inhibit demethylase enzymes. To sum up, the research showed that U251 cells lacking hypotaurine synthesis were susceptible to epigenetic changes, and Wnt5a seemed to function as a cancer inhibitor in this scenario. It would be beneficial to reevaluate this tumor suppressive effect in real tumor samples, which may contribute to the development of new glioma interference strategies.
format Article
id doaj-art-59bde30d5597470c8a73a3e2ce2f1bbc
institution DOAJ
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-59bde30d5597470c8a73a3e2ce2f1bbc2025-08-20T03:13:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01205e031205510.1371/journal.pone.0312055Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.Hong TianXiaoli ChuQi GuanJuan LiuYing LiuGlioma is a particularly lethal central nervous system tumor. Identifying the boundary between gliomas and normal tissues is difficult due to their infiltrative and invasive growth characteristics. This can result in the inevitable recurrence of the tumor after surgery. Preventing the residual tumor from growing or spreading is a major obstacle in treating gliomas. An earlier study suggested that hypotaurine could enhance the invasion of glioma cells while inhibiting the activity of demethylases. The hypotaurine synthesis-deficient U251 cell line usage showed a decrease in the cells' invasion capability. Analysis of gene expression profiles showed that reducing the activity of a critical enzyme in hypotaurine production, 2-aminoethanethiol dioxygenase (ADO), had a notable effect on the extracellular matrix-receptor interaction. Decreased intracellular ADO expression led to a significant increase in Wnt5a expression. Cells exposed to hypotaurine exhibited decreased levels of both intracellular Wnt5a protein and its corresponding mRNA. The observed characteristic was linked to increased methylation of the Wnt5a gene promoter, possibly due to hypotaurine's ability to inhibit demethylase enzymes. To sum up, the research showed that U251 cells lacking hypotaurine synthesis were susceptible to epigenetic changes, and Wnt5a seemed to function as a cancer inhibitor in this scenario. It would be beneficial to reevaluate this tumor suppressive effect in real tumor samples, which may contribute to the development of new glioma interference strategies.https://doi.org/10.1371/journal.pone.0312055
spellingShingle Hong Tian
Xiaoli Chu
Qi Guan
Juan Liu
Ying Liu
Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.
PLoS ONE
title Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.
title_full Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.
title_fullStr Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.
title_full_unstemmed Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.
title_short Hypotaurine promotes glioma cell invasion by hypermethylating the Wnt5a promoter.
title_sort hypotaurine promotes glioma cell invasion by hypermethylating the wnt5a promoter
url https://doi.org/10.1371/journal.pone.0312055
work_keys_str_mv AT hongtian hypotaurinepromotesgliomacellinvasionbyhypermethylatingthewnt5apromoter
AT xiaolichu hypotaurinepromotesgliomacellinvasionbyhypermethylatingthewnt5apromoter
AT qiguan hypotaurinepromotesgliomacellinvasionbyhypermethylatingthewnt5apromoter
AT juanliu hypotaurinepromotesgliomacellinvasionbyhypermethylatingthewnt5apromoter
AT yingliu hypotaurinepromotesgliomacellinvasionbyhypermethylatingthewnt5apromoter